E

Endocyte

18 employees

Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

mCRPC
Companion Imaging
Biotechnology
Health Care
CAR-T
Targeted drug therapy
Pharmaceutical
Cancer

Date founded

1996

Funding rounds raised

Total raised

$30M

from 16 investors over 16 rounds

E

Endocyte raised $15M on August 30, 2010

Investors: MidCap Financial

E

Endocyte raised $26M on January 19, 2010

Investors: Sanderling Ventures, Triathlon Medical Ventures, - and Blue Chip Venture Company

E

Endocyte raised $15M on March 26, 2007

Investors: Blue Chip Venture Company, Sanderling Ventures, -, Triathlon Medical Ventures and CID Capital

E

Endocyte raised $30M on November 13, 2006

Investors: -, Triathlon Medical Ventures, Blue Chip Venture Company and Sanderling Ventures

E

Endocyte raised $13M on May 22, 2003

Investors: Sanderling Ventures

E

Endocyte raised $7.6M on July 10, 2001

Investors: Sanderling Ventures

FAQ